Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 2/20 | 0.33 |
| ▸ | UGCG | Q16739 | 2/20 | 0.33 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5819788 | 1.00 | GBA1 (0.33) | GBA1UGCGGBA2TSHRALDH1A1 | |
| SCHEMBL5818100 | 0.98 | TSHR (0.34) | GBA1UGCGGBA2TSHR | |
| SCHEMBL19729210 | 0.93 | TSHR (0.31) | TSHR | |
| 1,6-Hexanediol SCHEMBL5819793 | 0.93 | PTGS1 (0.30) | — | |
| 1,4-Butanediol SCHEMBL5818104 | 0.91 | PTGS1 (0.31) | — | |
| SCHEMBL29581677 | 0.91 | TSHR (0.39) | GBA1UGCGGBA2TSHRALDH1A1 | |
| SCHEMBL11759538 | 0.89 | TSHR (0.40) | TSHRALDH1A1TDP1 | |
| SCHEMBL5822042 | 0.88 | TSHR (0.32) | TSHR | |
| SCHEMBL13935572 | 0.86 | TSHR (0.35) | TSHR | |
| SCHEMBL14256258 | 0.85 | MEN1 (0.38) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10428032-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20180022716-A1 | POLYMERIZABLE COMPOUND AND OPTICAL ISOMER | DIC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20170362508-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-12-21 | — | — | US | disclosed |
| US-20170362508-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-12-21 | — | — | US | disclosed |
| WO-2017079867-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428032-B2 | Polymerizable compound and optically anisotropic body | CCNY, F12, CCNI | GBA1 2310/4885UGCG 1530/4885GBA2 2451/4885 |
| US-20170362508-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | PBDC1, RCC1, PUF60 | GBA1 1167/4885UGCG 1656/4885GBA2 1132/4885 |
| US-20180022716-A1 | POLYMERIZABLE COMPOUND AND OPTICAL ISOMER | SMC4, MAP1LC3C, ZW10 | GBA1 2311/4885UGCG 1051/4885GBA2 1013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.